Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tacrolimus for treatment of alopecia areata
jRCTs051180073Active, not recruiting
- Start
- Feb 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tacrolimus in alopecia areata (2 arms). Primary endpoint: Primary endpoint: hair regrowth at 12 weeks. Started Feb 2019; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
alopecia areata
Beyond the preview
Go deeper on jRCTs051180073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180073.